The International Classification of Diseases 11th Revision (ICD-11) is a global standard for health information and diagnostics. Developed by the WHO, ICD-11 provides a systematic framework for classifying diseases, disorders, injuries, and other related health conditions. This classification allows for detailed analysis of health trends and statistics worldwide, assisting in informing public health and clinical decision-making.
ICD-11 was officially adopted by the WHO in May 2019, marking a significant update from its predecessor, ICD-10. The new revision is fully electronic and has been designed to be more accessible and easier to implement, which is a significant shift from the paper-based ICD-10. Learn more...
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials:Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
